The global market report on the orphan drugs revealed a possibility of crossing a valuation of USD 355 Billion by the end of 2030 with a CAGR of 9.2% during the forecast period of 2022-2030. Market Research Future (MRFR) in an exclusive report revealed factors that may improve the market scenario by substantial margin in the coming years. These factors are growing demand for the orphan drugs for the treatments of rare diseases, increasing initiatives taken by various governments, and others. Orphan drugs are exclusive as their production rarely takes place under a normal circumstance